Published in Kidney Int on April 29, 2009
Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab (2013) 1.58
Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol (2013) 1.09
Microalbuminuria: causes and implications. Pediatr Nephrol (2011) 1.05
Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol (2016) 1.03
Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract (2011) 0.96
Endothelial factors and diabetic nephropathy. Diabetes Care (2011) 0.91
Obesity, oxidative stress, and fibrosis in chronic kidney disease. Kidney Int Suppl (2011) (2014) 0.90
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol (2015) 0.88
Role of the USF1 transcription factor in diabetic kidney disease. Am J Physiol Renal Physiol (2011) 0.87
Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol (2012) 0.85
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease. Cell Metab (2015) 0.84
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2015) 0.82
Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese. PLoS One (2012) 0.81
Bariatric surgery is associated with improvement in kidney outcomes. Kidney Int (2016) 0.80
Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control. Pharmacoepidemiol Drug Saf (2013) 0.79
Heart-type fatty acid binding protein is associated with proteinuria in obesity. PLoS One (2012) 0.77
Serum fetuin-A levels related with microalbuminuria in diet-induced obese rats. Biomed Res Int (2012) 0.77
Obesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox Balance. Antioxid Redox Signal (2016) 0.77
Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring. Clin Exp Nephrol (2016) 0.76
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia. Mol Syst Biol (2015) 0.76
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia. Mol Syst Biol (2015) 0.76
Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy. Can J Kidney Health Dis (2017) 0.76
Sex differences in the association between obesity and albuminuria among Korean adults: a cross-sectional study using the Korea National Health and Nutrition Examination Survey data. Clin Exp Nephrol (2016) 0.75
Obesity and kidney disease: Hidden consequences of the epidemic. Indian J Nephrol (2017) 0.75
The metabolic syndrome and chronic kidney disease. Transl Res (2016) 0.75
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease. Pharm Regul Aff (2014) 0.75
Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat Rev Nephrol (2017) 0.75
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Kidney Dis (Basel) (2017) 0.75
Role of nitric oxide (NO) metabolism and inflammatory mediators in childhood obesity. Inflamm Res (2011) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Pediatr Nephrol (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Clin Kidney J (2017) 0.75